Metformin trial dramatically reduces seizures in tuberous sclerosis
Mental health support at boarding schools helps only male students feel safe from bullying
29 March 2021SARS-CoV-2 positivity in asymptomatic-screened dental patients
29 March 2021Metformin trial dramatically reduces seizures in tuberous sclerosis
A team of researchers led by UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) has found that metformin—a drug commonly used to treat Type 2 diabetes—can successfully reduce symptoms associated with tuberous sclerosis complex (TSC), including reduction in the frequency of seizures and the size of brain tumors.
